Literature DB >> 8175952

Skeletal growth factors and aging.

E Canalis.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8175952     DOI： 10.1210/jcem.78.5.8175952

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

Review 1.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

2.  Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat.

Authors:  G N Mann; D A Sass; H K Chen; F J Buchinsky; H P Bryer; Y F Ma; W S Jee; B Rucinski; S Epstein
Journal:  Calcif Tissue Int       Date:  1996-07       Impact factor: 4.333

3.  Regulation of insulin-like growth factors and their binding proteins by thyroid stimulating hormone in human osteoblast-like (SaOS2) cells.

Authors:  G Ramajayam; R C Vignesh; S Karthikeyan; K Senthil Kumar; G D Karthikeyan; S Veni; M Sridhar; J Arunakaran; M Michael Aruldhas; N Srinivasan
Journal:  Mol Cell Biochem       Date:  2012-06-07       Impact factor: 3.396

Review 4.  Growth factor control of bone mass.

Authors:  Ernesto Canalis
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

5.  Relationships between the insulin-like growth factor I (IGF-I) receptor gene G3174A polymorphism, serum IGF-I levels, and bone mineral density in postmenopausal Korean women.

Authors:  Dong Ock Lee; Byung Chul Jee; Seung-Yup Ku; Chang Suk Suh; Seok Hyun Kim; Young Min Choi; Shin Yong Moon; Jung Gu Kim
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

Review 6.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 7.  Function of matrix IGF-1 in coupling bone resorption and formation.

Authors:  Janet L Crane; Xu Cao
Journal:  J Mol Med (Berl)       Date:  2013-09-26       Impact factor: 4.599
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.